GENinCode Partners with Thermo Fisher to Commercialize Heart Disease Test

GENinCode Partners with US-based Thermo Fisher to Commercialize Heart Disease Test. GENinCode, a UK-based polygenics company, operates in the UK, Europe, and the US. Its predictive technology provides patients and physicians with preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict cardiovascular disease.